Boceprevir Treatment in Liver Pre-transplant HCV Patients
NCT02160080
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Late Complication From Liver Transplant
Interventions
DRUG:
Boceprevir 800mg/TID+Pegylated interferon alfa+Ribavirin
Sponsor
Hu Tsung-Hui